Pharmacy

MADOPAR Prolopa

Home » Prescription Drugs 10 » MADOPAR Prolopa

Levodopa is one of several drugs used to treat ParkinsonЖs disease. A progressive disorder ParkinsonЖs disease is associated with the reduced production of dopamine (an important neurotransmitter) by the brain. This in turn leads to problems with movement and coordination that worsen over time. Levodopa helps to mitigate movement problems because of its chemical similarity to dopamine. In fact levodopa is converted into dopamine once inside the body.In general levodopa is considered the most effective treatment available for ParkinsonЖs disease and its symptoms. Levodopa is often given in combination with another drug called carbidopa. This combination is known as Sinemet. It may provide significant benefit for five or more years.

Buy MADOPAR Prolopa and other Prescription Drugs 10 products online at Medstore.

Buy Online at Medstore - Click Here!

About MADOPAR Prolopa:

Product Type: Prescription Drugs 10

MADOPAR ( Prolopa Generic Levodopa/Benserazide )

MADOPAR (Prolopa Generic Levodopa/Benserazide)

Prolopa Generic Levodopa/Benserazide

200/50 Prolopa Generic Levodopa/Benserazide MADOPAR

View more Prescription Drugs 10

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.